- [Op-Ed] Patients, no time left for 'new drug comb therapies'
- Special Contribution | Eo, Yun-Ho
-
- "New landscape in DLBCL trt…Columvi·Polivy's bigger role"
- Professor Gareth Gregory of Monash University in Australia
-
- "Gilead-Kite will lead the trt landscape for DLBCL in KOR"
- Diego Santoro, Head of the International Region for Kite Pharma
MOST READ
